Loading
blood draws / Lung Cancer Screening / Low Dose CT imaging · Observational Study
ClinicalTrials.gov · September 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an observational registry study registered to enroll 409 participants and follow them for 2 years to measure lung cancer incidence in people with unexplained weight loss undergoing low-dose CT screening and blood-based testing. No results are yet reported in this registry record, and the study remains actively recruiting.
Observational. Lung Cancer Screening; age from 50 Years; to 80 Years; accepts healthy volunteers. Intervention: Patients undergoing Lung cancer screening. n = 409. 8 sites: United States.
This is an observational registry study registered to enroll 409 participants and follow them for 2 years to measure lung cancer incidence in people with unexplained weight loss undergoing low-dose CT screening and blood-based testing. No results are yet reported in this registry record, and the study remains actively recruiting.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is an ongoing observational registry study with no results yet posted; it is designed to explore whether unexplained weight loss enriches lung cancer screening yield, but enrollment and follow-up are incomplete.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06717334). This is a study registration, not published results. Lead sponsor: Memorial Sloan Kettering Cancer Center. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 409 participants (ESTIMATED). Conditions: Lung Cancer Screening. Interventions: DIAGNOSTIC_TEST: Low Dose CT imaging; OTHER: blood draws; OTHER: screening questionnaire. Primary outcome measures: The incidence of lung cancer in patients with unexplained weight loss , 2 years. Brief summary: The researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography (LDCT), a CT scan that gives off very low doses of radiation and can make detailed pictures of the lungs to help find tumors. The study researchers will also analyze participants' blood samples to determine if blood testing can be used to help to diagnose lung cancer.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.